نتایج جستجو برای: prolyl dipeptidyl peptidase

تعداد نتایج: 14385  

2018
Ghaith Al-Badri Gian Marco Leggio Giuseppe Musumeci Rubina Marzagalli Filippo Drago Alessandro Castorina

Dipeptidyl peptidase IV (DPP-IV) is a serine protease best known for its role in inactivating glucagon-like peptide-1 (GLP-1), pituitary adenylate cyclase-activating polypeptide (PACAP) and glucose-dependent insulinotropic peptide (GIP), three stimulators of pancreatic insulin secretion with beneficial effects on glucose disposal. Owing to the relationship between DPP-IV and these peptides, inh...

2010
Vivian C. Luft Maria Inês Schmidt James S. Pankow Ron C. Hoogeveen David Couper Gerardo Heiss Bruce B. Duncan

OBJECTIVE Dipeptidyl peptidase IV (DPP-IV) is not only important in beta-cell function but also has proinflammatory actions. We aimed to investigate whether it could act as a link between low-grade chronic inflammation and diabetes. RESEARCH DESIGN AND METHODS Using a case-cohort design, we followed 546 middle-aged individuals who developed diabetes and 538 who did not over approximately 9 ye...

Journal: :Indian Journal of Endocrinology and Metabolism 2011

2013
Henrike Sell Matthias Blüher Nora Klöting Raphaela Schlich Miriam Willems Florian Ruppe Wolfram Trudo Knoefel Arne Dietrich Barbara A. Fielding Peter Arner Keith N. Frayn Jürgen Eckel

OBJECTIVE To study expression of the recently identified adipokine dipeptidyl peptidase-4 (DPP4) in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) of patients with various BMIs and insulin sensitivities, as well as to assess circulating DPP4 in relation to obesity and insulin sensitivity. RESEARCH DESIGN AND METHODS DPP4 expression was measured in SAT and VAT from 196 sub...

2017
Polly A. Bittle

There is a need for treatment options in patients with type 2 diabetes mellitus and kidney disease to achieve glucose targets without risk of hypoglycemia. This article describes management options for these patients using glucose-lowering therapies, in particular dipeptidyl peptidase-4 inhibitors.

Journal: :Dermatology Reports 2023

Bullous pemphigoid (BP) is an autoimmune disease with a chronic relapsing course, predominantly affecting elderly people. Drugs are one of the possible triggers. A class antidiabetic drugs often associated development BP inhibitors dipeptidyl peptidase 4 (DPP-4 or gliptins), while less known association glucagon-like-peptide-1 (GLP-1) receptor agonists. We describe case caused by dulaglutide an...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید